As forecasted by analysts from Future Market Insights (FMI), the deblistering machines market is poised for growth in 2023, surpassing a valuation of US$ 165.0 million. Projections indicate a noteworthy uptrend, with the market’s value projected to witness a 5.0% increase between 2023 and 2033, resulting in an anticipated valuation of US$ 270.0 million by 2033. This growth trajectory underscores the rising demand for efficient pharmaceutical packaging processes. As the market embraces advancements in deblistering technology, the anticipated CAGR of 5.0% signifies sustained industry expansion, reflecting the sector’s adaptability to evolving pharmaceutical packaging requirements.
The demand for highly efficient deblistering machines for the secure and safe removal of tablets and capsules from blister packs has witnessed a significant surge in the last couple of years and is projected to enjoy astonishing demand during the forecast period.
At the conclusion of the analytical timeframe, the Indian deblistering machines market is anticipated to showcase a robust Compound Annual Growth Rate (CAGR) of 7.2%. Projections suggest that the market size will ascend to US$ 13.3 million in 2023, doubling to US$ 26.4 million by the study period’s conclusion. India, as a prominent player in the global pharmaceutical landscape, maintains a crucial role by serving as a major producer of both generic and branded medicinal drugs. The country’s continuous contributions to pharmaceutical production underscore its significance in meeting the global demand for pharmaceuticals on a substantial scale.
Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6645
Research-based German pharmaceutical industry is more inclined towards the launch of new medicinal drugs and extension of product pipelines. Strong capital investment in drug development in Germany is redefining the pharmaceutical market’s growth in the country.
As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), the capital invested in research and development in German Pharmaceutical Industry was US$ 9,440 million in 2019, which is the highest among the other European countries.
Key Takeaways from Deblistering Machines Market
- Automatic deblistering machines are projected account for more than 70% of the overall market share driven by higher operational speed.
- 40 to 80 BPM machines will remain dominant in the market, while the over 80 BPM machines are estimated to reflect faster growth with an incremental opportunity of US$ ~ 24.3 Mn.
- With the frequent use of deblistering machines in the pharma sector, the U.S. market is expected to expand by more than1.5 times.
- Manufacturers are capitalizing on opportunities across lucrative markets such as India and China.
- Expansion of healthcare sector will spur y-o-y growth in the U.K. at 2.8% in 2021.
The rise in production of medicinal drugs, especially those requiring oral dosages such as tablets and capsules has created lucrative opportunities for deblistering machine manufacturers to maximize their sales. Rising emphasis on safe and secure removal of medicinal tablets and capsules with high-precision deblistering processes is anticipated to redefine the market growth,” says FMI analyst.
Deblistering Machines Market Landscape
- Omnicell, Inc,
- Uhlmann Pac-Systeme GmbH & Co. KG,
- ACG Worldwide Private Limited
are the top players operating in the deblistering machines market. Furthermore,
- RBP Bauer GmbH,
- Jornen Machinery Co., Ltd,
- Sepha Limited,
- Stripfoil Deblistering Technology,
- Elmach Packages India Pvt. Ltd
are also the noticeable players in the deblistering machines market.
The Tier 3 players in the market hold 65-70% in the global deblistering machines market. In conclusion, key players contribute almost 30-35% of the global market. Leading players in the industry are increasingly focused on investments into product development to expand portfolios, consolidating overall market position.
Recent Development
Considering the current need from the pharmaceutical sector, leading packaging machinery manufacturers are offering deblistering machinery with next-level automation. Manufacturers operating in the global deblistering machines market are designing, manufacturing, and offering deblistering machines that are suitable for end-users. This can be exemplified by
- Stripfoil Deblistering Technology’s deblistering machine, which has a fully automated deblistering operation coupled with an operating speed of 80 to 140 blisters per minute. The same deblistering machines are capable of deblistering almost all types of blister formats.
- SEPHA, manufacturer of deblistering machines, has designed deblistering machines with features such as automatic feed and user interface with fault indicators, easy tooling changeover, variable speed of up to 60 blisters per minute, and others. The demand for such end-use industry-oriented deblistering machines is propelling in the market, owing to its innovative features, which further reinforces the market growth.
Market Drivers:
- Increased Pharmaceutical Production: The demand for deblistering machines is often influenced by the overall growth in the pharmaceutical industry. As pharmaceutical production increases globally, the need for efficient and automated deblistering processes also rises.
- Regulatory Compliance: Stringent regulations in the pharmaceutical sector regarding product safety and quality drive the adoption of advanced machinery, including deblistering machines. Manufacturers invest in compliant equipment to meet regulatory standards.
- Rising Healthcare Expenditure: Increased healthcare spending and a growing focus on healthcare infrastructure in emerging markets contribute to the demand for pharmaceutical packaging and processing machinery, including deblistering machines.
Business Trends:
- High Initial Investment: The initial cost of acquiring and installing deblistering machines can be significant, posing a challenge for smaller pharmaceutical companies or manufacturers with budget constraints.
- Limited Awareness: Some pharmaceutical companies may not be fully aware of the benefits and capabilities of modern deblistering machines. Limited awareness and understanding of the technology can hinder adoption.
- Dependency on Pharmaceutical Industry Growth: The deblistering machines market is closely tied to the overall growth of the pharmaceutical industry. Economic downturns or fluctuations in pharmaceutical demand can impact the market for deblistering machines.
- Compatibility Issues: Integration of deblistering machines with existing packaging lines or processes can be challenging, especially if there are compatibility issues. This may act as a barrier to adoption for some companies.
Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/6645
Key Segments Covered in Deblistering Machines Industry Research
Automation:
- Automatic
- Semi-Automatic
- Manual
Operating Speed:
- Up to 40 BPM
- 40 to 80 BPM
- Above 80 BPM
End Use:
- Pharmaceutical Manufacturers
- Pharmacies
- Hospitals & Clinical Laboratories
- Medical Waste Recyclers
- Contract Manufacturers
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube